Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trialFrançois-Xavier Lescure, Stéphane Doucet, Hitoshi Honda et al.|The Lancet Respiratory Medicine|2021Cited by 248
Risks of hepatitis C virus reactivation in a real-life population of oncology patients treated in an academic centerC Boutin, Valérie Martel‐Laferrière, Jean‐Philippe Adam et al.|Journal of Oncology Pharmacy Practice|2020Cited by 3